United Therapeutics settles patent litigation over $157M drug

United Therapeutics has settled patent litigation over a $157 million drug. The company (Nasdaq: UTHR) reached an agreement with Actavis Laboratories FL, which is a subsidiary of generic giant Teva Pharmaceuticals, that resolves litigation over certain patents related to one of United Therapeutics' pulmonary arterial hypertension drugs: Orenitram. United Therapeutics repo rted upward of $157 million in revenue from Orenitram in 2016, with total revenue at roughly $1.6 billion.  The settlement…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news